Hikma Pharmaceuticals plc/ GB00B0LCW083 /
2024-04-17 3:49:27 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
22.3300USD | - | 204 Turnover: 4,555.3200 |
-Bid Size: - | -Ask Size: - | 4.92 bill.USD | 3.24% | 25.87 |
GlobeNewswire
2021-02-25
Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
GlobeNewswire
2021-01-26
Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care Insu...
GlobeNewswire
2020-01-09
Arecor and Hikma Announce Exclusive Agreement to Develop and Commercialise Ready-To-Use Medicine Usi...
GlobeNewswire
2019-06-03
Gout Therapeutic Market is projected to reach US$ 3820 Million by 2027- TMR